These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 657087)

  • 21. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
    Matchett KM; Huang AT; Kremer WB
    J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hodgkin's disease: study of delayed hypersensitivity of 64 non treated patients. Value of epicutaneous test using croton oil].
    Goasguen J; Leblay R; Guerin D; Le Prise PY; Richier JL
    Sem Hop; 1977 Jan; 53(4):219-25. PubMed ID: 189435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prognostic value of determination of the degree of PHA-stimulated blastic transformation of lymphocytes in Hodgkin's disease].
    Pluzańska A
    Pol Arch Med Wewn; 1977 Apr; 57(4):307-11. PubMed ID: 859748
    [No Abstract]   [Full Text] [Related]  

  • 24. Deficiency of lymphocyte antigen recognition in Hodgkin's disease.
    Gaines JD; Gilmer MA; Remington JS
    Natl Cancer Inst Monogr; 1973 May; 36():117-21. PubMed ID: 4744572
    [No Abstract]   [Full Text] [Related]  

  • 25. [Assays in delayed hypersensitivity in the course of Hodgkin's disease].
    Bernadou A; Zittoun R; Blanc CM; Smadja R; Bousser J
    Ann Med Interne (Paris); 1970 Mar; 121(3):301-11. PubMed ID: 5507504
    [No Abstract]   [Full Text] [Related]  

  • 26. A prospective study of the changes in the immune status before, during, and after multiple-agent chemotherapy for Hodgkin's disease.
    Van Rijswijk RE; Sybesma JP; Kater L
    Cancer; 1983 Feb; 51(4):637-44. PubMed ID: 6821837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro lymphocyte response to the phytomitogens in untreated and treated patients with Hodgkin's disease.
    Romagnani S; Amadori A; Biti G; Bellesi G; Ricci M
    Int Arch Allergy Appl Immunol; 1976; 51(3):378-89. PubMed ID: 1279027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hodgkin's disease and granulomatous uveitis.
    Mosteller MW; Margo CE; Hesse RJ
    Ann Ophthalmol; 1985 Dec; 17(12):787-90. PubMed ID: 4091380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epithelioid granulomas in Hodgkin's disease--prognostic significance.
    Chopra R; Rana R; Zachariah A; Mahajan MK; Prabhakar BR
    Indian J Pathol Microbiol; 1995 Oct; 38(4):427-33. PubMed ID: 9726157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delayed cutaneous hypersensitivity and blood lymphocyte count in advanced Hodgkin's and non-Hodgkin's lymphomas.
    Gupta S; Seth SK; Udupa KN; Sen PC; Rastogi BL
    Ann Chir Gynaecol; 1980; 69(2):79-83. PubMed ID: 7377739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Degrees of impairment of cell-mediated immune reactivity in Hodgkin's disease.
    Petrov M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(2):201-10. PubMed ID: 61913
    [No Abstract]   [Full Text] [Related]  

  • 32. Blastoid lymphocyte transformation assay in malignant tumours of lymphopoietic tissue: in Hodgkin's disease, reticulosarcoma, lymphosarcoma and chronic lymphatic leukaemia. Relationship to the clinical status and to the delayed type of hypersensitivity.
    Libánský J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1973; 100(1):51-6. PubMed ID: 4128515
    [No Abstract]   [Full Text] [Related]  

  • 33. Hodgkin's disease. Immunologic, clinical, and histologic features of 50 untreated patients.
    Brown RS; Haynes HA; Foley HT; Godwin HA; Berard CW; Carbone PP
    Ann Intern Med; 1967 Aug; 67(2):291-302. PubMed ID: 6036391
    [No Abstract]   [Full Text] [Related]  

  • 34. Quantitation of T and B lymphocytes and cellular immune function in Hodgkin's disease.
    Bobrove AM; Fuks Z; Strober S; Kaplan HS
    Cancer; 1975 Jul; 36(1):169-79. PubMed ID: 54208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prolonged and repeated stimulation with PHA and lymphocyte blastic response in Hodgkin's disease].
    Ippoliti G; Marini G; Ascari E; Casirola G
    Haematologica; 1973; 58(7):437-42. PubMed ID: 4200981
    [No Abstract]   [Full Text] [Related]  

  • 36. Impaired delayed-hypersensitivity responses in 154 patients with untreated Hodgkin's disease.
    Eltringham JR; Kaplan HS
    Natl Cancer Inst Monogr; 1973 May; 36():107-15. PubMed ID: 4582989
    [No Abstract]   [Full Text] [Related]  

  • 37. SPLEEN/PATHOL.
    Bukowski RM; Noguchi S; Hewlett JS; Deodhar S
    Am J Clin Pathol; 1976 Jan; 65(1):30-9. PubMed ID: 1082240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative studies of the proportions of T, B and O-lymphocytes and of the degree of blastic transformation following stimulation with PHA in patients with Hodgkin's disease].
    Pluzańska A
    Pol Arch Med Wewn; 1977 Apr; 57(4):297-305. PubMed ID: 300871
    [No Abstract]   [Full Text] [Related]  

  • 39. [Preliminary data on phytohemagglutinin-induced blastic transformation of lymph-node cells of patients with Hodgkin's disease].
    Tognella S; Mantovani G; Floris C; Del Giacco GS; Grifoni V
    Boll Soc Ital Biol Sper; 1972 Jul; 48(14):386-9. PubMed ID: 5082521
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunity of Epstein-Barr virus in Hodgkin's disease preceded by infectious mononucleosis.
    Band PR; Levine PH; Patwardhan VC; Shnitka TK; Pabst HF
    Can Med Assoc J; 1973 Jan; 108(2):183-6. PubMed ID: 4346314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.